Back to Studies
P1100 / AERAS 402
A Phase II, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety and Immunogenicity of AERAS-402 in BCG-vaccinated, HIV-uninfected Infants Without Evidence of Tuberculosis
Study Status
Concluded
DAIDS Number
11801
IND Number
No IND (see comment)
Primary Protocol Team Members
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...